This study aims to analyze the prevalence trend of esophageal cancer in Japan and China to provide suggestions for the prevention and treatment of esophageal cancer. The results showed that the incidence rate for the years 2010-2018 significantly decreased with an APC of 5.66%, and the mortality rate from 2010 to 2015 had an APC of -5.87% in China. However, the incidence rate of Japanese women showed an upward trend, with an APC of 4.09% from 2010 to 2019. The mortality rate of esophageal cancer in Japan showed a downward trend, with an APC of -2.96% from 2010 to 2021. From 2010 to 2018, Chinese esophageal squamous cell carcinoma accounted for the highest proportion, accounting for 85.96%, with the largest distribution in the middle, accounting for 47.25%. Patients are mostly diagnosed at stage III, and the relative survival rate from 2012 to 2015 was 30.3%. Japan also has the highest proportion of squamous cell carcinoma, and the lesions are also mostly located in the middle segment. While Japanese esophageal cancer patients are mostly diagnosed at stage I, and the relative survival rate was 41.5% in Japan from 2009 to 2011. The results of this article indicate that the current prevalence of esophageal cancer in China and Japan is generally declining, and the quality of life of patients is gradually improving, but effective screening and prevention strategies are still needed to reduce the burden of this disease. The incidence of esophageal cancer is disproportionately high in East Asia, where China alone has historically accounted for about half of the world's esophageal malignancies. In this study, the authors investigated recent trends in incidence and mortality for esophageal cancer specifically in China and Japan. Analyses show that incidence and mortality rates are declining in China, while mortality is declining in Japan. Most patients are diagnosed at stage III in China, versus stage I in Japan. The findings offer insight into esophageal cancer trends and patterns in China and Japan and could help identify areas for improvement in prevention. image
第一作者机构:[1]Hebei Med Univ, Fourth Hosp, Canc Inst, Shijiazhuang, Peoples R China
通讯作者:
通讯机构:[1]Hebei Med Univ, Fourth Hosp, Canc Inst, Shijiazhuang, Peoples R China[2]Aichi Med Univ, Sch Med, Dept Publ Hlth, Nagakute, Aichi, Japan[*1]Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China[*2]Department of Public Health, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
推荐引用方式(GB/T 7714):
Guo Dongli,Jin Jing,Li Daojuan,et al.Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan[J].INTERNATIONAL JOURNAL OF CANCER.2024,155(8):1376-1386.doi:10.1002/ijc.35003.
APA:
Guo, Dongli,Jin, Jing,Li, Daojuan,He, Yutong&Lin, Yingsong.(2024).Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan.INTERNATIONAL JOURNAL OF CANCER,155,(8)
MLA:
Guo, Dongli,et al."Analysis of the incidence and mortality trends of esophageal cancer in cancer registry areas of China and Japan".INTERNATIONAL JOURNAL OF CANCER 155..8(2024):1376-1386